Dietary ω-3 polyunsaturated fatty acid intake improves skeletal muscle mass in patients with metabolic dysfunction-associated fatty liver disease: A nationwide cross-sectional study

Figure 1 Flowchart of study design and exclusion criteria for adults from National Health and Nutrition Examination Survey 2011–2018. NHANES: National Health and Nutrition Examination Survey; PUFAs: Polyunsaturated fatty acids; MAFLD: Metabolic-dysfunction-associated fatty liver disease; FLI: Fatty liver index; BMI: Body mass index; ASMI: Appendicular skeletal muscle mass index.